Quantcast

Latest rheumatism Stories

2010-02-25 09:45:00

SSRIs offer model for drug development opportunities to treat rheumatoid arthritis A new study found that fluoxetine (Prozac®) and citalopram (Celexa®) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D. from the Brighton and Sussex Medical School (BSMS) in the UK studied the anti-arthritic potential of these drugs, known as selective serotonin reuptake inhibitors (SSRIs),...

2010-02-19 15:12:23

Contrast-enhanced magnetic resonance imaging (MRI) may help physicians differentiate between rheumatoid arthritis and psoriatic arthritis in the hand and wrist enabling more targeted therapies unique to each condition, according to a study in the March issue of the American Journal of Roentgenology. Contrast-enhanced MRI uses contrast media to improve the visibility of internal bodily structures. Rheumatoid arthritis is a long-term disease that leads to inflammation of the joints and...

2010-02-04 07:30:00

WASHINGTON, Feb. 4 /PRNewswire/ -- The Centers for Disease Control and Prevention (CDC) and the Arthritis Foundation today announced a major initiative to dramatically reduce the impact of osteoarthritis on Americans. In conjunction with the announcement, the Arthritis Foundation and the Ad Council are unveiling a national public awareness campaign today in response to the recommendations outlined in the action plan, A National Public Health Agenda for Osteoarthritis. To view the...

2010-01-28 13:16:52

Researcher invents nontoxic drug that forces hyperactive immune cells to die A researcher from Northwestern University Feinberg School of Medicine has invented a novel way to halt and even reverse rheumatoid arthritis. He developed an imitation of a suicide molecule that floats undetected into overactive immune cells responsible for the disease. Whimsically referred to as Casper the Ghost, the stealthy molecule causes the immune cells to self-destruct. The approach, tested on mice, doesn't...

2010-01-28 11:46:08

Largest US study to date finds mortality outcomes improving A recent study by researchers from the Cleveland Clinic found that the overall mortality rate in the U.S. for all pediatric patients with rheumatic diseases was not worse than the age and sex-adjusted population. Furthermore, mortality rates were significantly lower than reported in previous studies of rheumatic diseases and conditions that are associated with increased mortality. Details of the study appear in the February issue of...

2010-01-28 11:42:56

Study confirms elevated cytokine levels are early indicator of disease Researchers from University Hospital in Umea, Sweden, have identified several cytokines, cytokine-related factors, and chemokines that increase significantly prior to rheumatoid arthritis (RA) disease onset. These findings confirm those of earlier studies which suggest that the risk of developing RA can be predicted and disease progression may be prevented. Complete findings of this study are published in the February...

2010-01-10 13:14:12

Work done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease. In addition, the international research team pinpointed two areas along stretches of DNA that play an important role in regulating gene activity associated with the arthritic condition. The findings, a critical milestone in the understanding of AS, are...

2010-01-06 12:24:35

Rituximab treatment reduced patient response to pneumonia vaccine Researchers from Johns Hopkins University determined that immune responses to the tetanus vaccine were not changed when rituximab in combination with methotrexate (MTX) was compared with MTX alone in patients with rheumatoid arthritis (RA). Responses to a pneumococcal vaccination (Pneumovax® pneumonia vaccine), however, were reduced in RA patients with rituximab. Complete findings of this study are published...

2010-01-06 12:11:51

Influenza vaccine not adversely affected by RA drug methotrexate Rheumatoid arthritis (RA) patients are partially protected by the influenza vaccine 6-10 months after treatment with rituximab. Researchers determined that while the flu vaccine is safe, it is ineffective for RA patients in the first 6 months following rituximab treatment. Previous influenza vaccination in rituximab-treated patients does increase pre- and post-vaccination titers, providing some defense to influenza strains. RA...

2010-01-05 20:00:23

Study finds self-management alone may effectively treat early OA Researchers participating in the Multidimensional Intervention for Early Osteoarthritis of the Knee (Knee Study) determined that physically inactive, middle-aged people with symptomatic osteoarthritis benefited equally from strength training regimens, self-management programs, or a combination of the two. Details of this study are available in the January 2010 issue of Arthritis Care & Research, a journal published by...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related